Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries with type 2 diabetes and heart failure, atherosclerotic cardiovascular disease and chronic kidney disease, 2013–2019

Diabetologia(2024)10.1007/s00125-024-06321-2Source: DataRank Database

Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries with type 2 diabetes and heart failure, atherosclerotic cardiovascular disease and chronic kidney disease, 2013–2019 is a research paper published in Diabetologia (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.94)OA: hybridTopics (45)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Elisabetta Patorno ORCID,Farzin Khosrow‐Khavar ORCID,Stephen Crystal ORCID,Chintan V. Dave ORCID,Eric Wang ORCID

Live enrichment

PubMed:39514094 PMC:PMC11663158 OpenAlex:https://openalex.org/W4404186491

NIH

Grant: 1R01HL163163

NIA NIH HHS

Grant: L30 AG069245

NIDDK NIH HHS

Grant: R01 DK139163

NHLBI NIH HHS

Grant: R01 HL163163

FWCI

2.94

Citation Percentile

0.9%

Influential Citations

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s00125-024-06321-2.pdf

HYBRIDhttps://link.springer.com/content/pdf/10.1007/s00125-024-06321-2.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00125-024-06321-2.pdf

publisherhttps://link.springer.com/article/10.1007/s00125-024-06321-2/fulltext.html

journalhttps://doi.org/10.1007/s00125-024-06321-2

Fields of Study

Diabetes Treatment and ManagementHeart Failure Treatment and ManagementMedication Adherence and ComplianceMedicine

MeSH Terms

Glucagon-Like Peptide-1 ReceptorSodium-Glucose Transporter 2 InhibitorsWhiteGlucagon-Like Peptide-1 Receptor AgonistsAgedAged, 80 and overBlack or African AmericanDiabetes Mellitus, Type 2EthnicityFemaleMedicareHeart FailureHispanic or LatinoHumansMaleRetrospective StudiesUnited StatesWhite PeopleAtherosclerosisRenal Insufficiency, ChronicHealthcare Disparities

Keywords

Type 2 diabetesMedicineDiseaseEthnic groupHeart failureDiabetes mellitusKidney diseaseInternal medicineCardiologyIntensive care medicineEndocrinologyPolitical scienceDiabetesChronic Kidney DiseaseOlder PeopleDisparitiesMedicareCvdSglt2 InhibitorGlp-1 Receptor Agonist

Sustainable Development Goals

SDG 0: Good health and well-being